J&J's Darzalex pads blockbuster sales with another myeloma nod in new patients
admin 28th June 2019 Uncategorised 0Johnson & Johnson multiple myeloma drug Darzalex hasn’t stopped rolling since hitting the market. After picking up its first nod in previously untreated patients last May, the drug added a second green light on Thursday in new patients—its sixth overall.
read more